Literature DB >> 10417613

Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice.

M G Mahoney1, Z H Wang, J R Stanley.   

Abstract

Previous studies have suggested that urokinase plasminogen activator is required for blister formation in pemphigus vulgaris and pemphigus foliaceus. Other studies, however, have shown that downregulation of plasminogen activator does not inhibit blisters induced by pemphigus immunoglobulin G. To eliminate the possibility that small amounts of urokinase plasminogen activator might be sufficient for blister formation, we passively transferred pemphigus immunoglobulin G to urokinase plasminogen activator knockout neonatal mice. Pemphigus foliaceus and pemphigus vulgaris immunoglobulin G caused gross blisters and acantholysis in the superficial and suprabasal epidermis, respectively, to the same degree in knockout and control mice, demonstrating that urokinase plasminogen activator is not absolutely required for antibody-induced blisters. Some studies have shown elevated tissue-type plasminogen activator in pemphigus lesions. Tissue-type plasminogen activator, however, is not necessary for blister formation, because pemphigus foliaceus and pemphigus vulgaris immunoglobulin G caused blisters to the same degree in tissue-type plasminogen activator knockout and control mice. To rule out that one plasminogen activator might compensate for the other in the knockout mice, we bred urokinase plasminogen activator, tissue-type plasminogen activator double knockouts. After passive transfer of pemphigus foliaceus and pemphigus vulgaris immunoglobulin G these mice blistered to the same degree as the single knockout and control mice, and histology indicated blisters at the expected level of the epidermis. These data definitively demonstrate that plasminogen activator is not necessary for pemphigus immunoglobulin G to induce acantholysis in the neonatal mouse model of pemphigus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417613     DOI: 10.1046/j.1523-1747.1999.00632.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  p38MAPK inhibition prevents disease in pemphigus vulgaris mice.

Authors:  Paula Berkowitz; Peiqi Hu; Simon Warren; Zhi Liu; Luis A Diaz; David S Rubenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

Review 2.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

3.  Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin.

Authors:  Paula Berkowitz; Michael Chua; Zhi Liu; Luis A Diaz; David S Rubenstein
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

4.  Desmosomal molecules in and out of adhering junctions: normal and diseased States of epidermal, cardiac and mesenchymally derived cells.

Authors:  Sebastian Pieperhoff; Mareike Barth; Steffen Rickelt; Werner W Franke
Journal:  Dermatol Res Pract       Date:  2010-06-30

5.  Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.

Authors:  E Schmidt; B Wehr; E M Tabengwa; S Reimer; E-B Bröcker; D Zillikens
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

6.  Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation.

Authors:  Anita J Merritt; Mohamed Y Berika; Wenwu Zhai; Sarah E Kirk; Baijing Ji; Matthew J Hardman; David R Garrod
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 7.  A perspective of pemphigus from bedside and laboratory-bench.

Authors:  Yasuo Kitajima; Yumi Aoyama
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 8.  Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis.

Authors:  Christian Veldman; Claudio Feliciani
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

9.  Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression.

Authors:  Isabelle Bolon; Hong-Ming Zhou; Yves Charron; Annelise Wohlwend; Jean-Dominique Vassalli
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Superficial dsg2 expression limits epidermal blister formation mediated by pemphigus foliaceus antibodies and exfoliative toxins.

Authors:  Donna Brennan; Ying Hu; Walid Medhat; Alicia Dowling; My G Mahoney
Journal:  Dermatol Res Pract       Date:  2010-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.